Industry Outlook

The 3D Printing Medical Devices industry is projected to grow from USD 3.9 Billion in 2024 to USD 30.6 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 20.6% from 2025 to 2035. The process of 3D printing includes the manufacturing of objects that are dimensionally solid which is mainly used in the health care sector and is known in the name of additive manufacturing. Additive processes are put into use to achieve 3D-printed objects. Multiple layers are successively laid on each other to create an object while using the additive process for manufacturing. The layouts present themselves as very thin sliced layers in the form of a cross-section obtained from the object. Customized medical devices and equipment that are utilized in the healthcare sector are manufactured with the help of this process.

Report Scope:

Market Dynamics

Increased use of digital manufacturing processes

The process of producing three-dimensional solid objects from digital designs/files is known as 3D printing, also called additive manufacturing. The digital revolution of dentistry and medical procedures has developed tremendously over recent years, aiming to improve clinical workflow through integrating technology. The industry is transitioning from conventional to digital dental care and surgeries. Direct digital manufacturing creates a physical object directly from a digital design using computer-controlled procedures. Direct digital manufacturing is becoming more widely used than traditional manufacturing techniques as 3D printing technology advances. 3D printing Medical Devices provide distinct benefits by eliminating the need for tooling, shortening the time between design and production, and increasing output. Medical printing devices provide numerous advantages to users throughout the healthcare lifecycle. 3D printing medical devices improve clinical outcomes and procedural efficiency while lowering reintervention costs, offering benefits as an overall treatment plan for complicated injuries, thereby driving the market expansion of 3D printing medical devices.

Rising difficulties regarding the overuse of nasal sprays

On the other hand, the difficulties regarding the overuse of nasal sprays are further projected to impede the growth of the nasal drug delivery technology market in the targeted period. Moreover, the regulatory hurdles might further challenge the growth of the nasal drug delivery technology market in the forecast future. Moreover, this restraint lies in the need for rigorous clinical trials, safety assessments, and regulatory approvals for any new medication or therapy. These stringent processes can prolong the timeline and increase the costs associated with bringing innovative treatments to market, resulting in potential breakthrough treatments which are expected to become the biggest and foremost challenge for the growth of the market in the forecast period of 2023-2030.

Increasing production accuracy to shape the market growth

The easy availability of nasal drugs and growing attention on alternative routes such as nasal drug delivery further provide potential opportunities for the growth of the nasal drug delivery technology market in the coming years. High production accuracy and growing demand for such technologically advanced devices are further estimated to provide potential opportunities for the growth of the healthcare 3D printing market in the coming years. Moreover, improvements in healthcare infrastructure in emerging markets have increased access to medical treatment, which will further expand the market and lead to the growth of the healthcare 3D printing market in the above-mentioned projected timeframe.

Industry Experts Opinion

“Highlights that the technology's ability to create complex structures is pushing the boundaries of regenerative medicine, especially in custom organ scaffolds.”

• Dr. Scott Hollister, A biomedical engineer

“Points out that as 3D printing costs decrease, its adoption in the medical field will surge, particularly in creating low-volume, high-complexity medical devices.

• Pete Basiliere, A former Gartner analyst

Segment Analysis

Based on the Type: The market segments of 3D printing medical devices based on types include surgical guides, prosthetics, and others. The rising prevalence of chronic diseases and the rising demand for prosthetic implants in developing countries account for a large portion of this segment. Customized medical products and equipment are one of the benefits that 3D printers in medical devices provide. As a result, custom-made prosthetics and implants benefit both patients and doctors. Moreover, customized implants improve surgery time, patient recovery time, and implant success. Other factors likely to fuel the prosthetics segment market growth in the forecast period include an increase in amputation cases globally and an increase in limb amputation due to cardiovascular disease. In January 2019, Apollo Hospitals in Mumbai, India, performed a 3D-printed titanium skull implant on one of its patients. The 3D-printed titanium prosthetics implant was chosen as it would accurately replicate the structure of the patient's skull. These 3D printed prosthetics are MRI compatible, reduce the risk of infection, and, most importantly, can be tailored to the patient's specific shape.

Based on the Technology: The spine industry is embracing 3D printing medical devices to create new innovative products that can enhance bone ingrowth and strengthen implant fixation to spine bone, thereby reducing the number of manufacturing steps and making the 3D printing technology more cost-effective across several cases. For example, Medtronic introduced TiONIC Technology, a titanium 3D-printed platform, that uses lasers to produce implants with improved surface textures. Artic-L is the company's first implant designed with TiONIC Technology.

Regional Analysis

North America is expected to maintain its dominance during the forecast period due to the three major countries of North America considered in the report including the U.S., Canada, and Mexico. North America is dominating the market of overall 3D printing in healthcare and is expected to dominate throughout the forecast period. This is attributed to the widespread adoption of 3D printing technology and numerous collaborations between academic and commercial organizations in this region. In addition, technological innovations pertaining to 3D printing, increase in funding for advancement in 3D printers for healthcare, and upsurge in the patient pool in this region has contributed to its dominance. An increase in acquisition, product launch, and product approval by key players of this market operating in North America will fuels the market growth.

Asia-Pacific is expected to expand at a significant growth rate during the forecast period of 2025 to 2035 due to the rise in the adoption rates of 3D and 4D technologies such as a bionic hand by Youbionic, which adds values to the overall experience. Moreover, the ongoing healthcare infrastructure and rising health care expenses are further anticipated to propel the growth of the healthcare 3D printing market in the region in the coming years.

Competitive Landscape

Some of the market's major players are Stratasys Ltd, Renishaw PLC, 3D Systems Inc., Nanoscribe GmbH & Co. KG, and Nano3D Biosciences Inc., among others. Stratasys Ltd. is a leading global provider of 3D printing and additive manufacturing solutions, renowned for its innovation in the healthcare sector. The company offers a range of 3D printers, materials, and software tailored for medical applications, including surgical planning, medical device prototyping, and the creation of patient-specific anatomical models. Stratasys' technology is instrumental in advancing personalized medicine, allowing for the production of custom implants, prosthetics, and surgical guides. Their J750 Digital Anatomy printer, in particular, is celebrated for its ability to replicate the feel, responsiveness, and biomechanics of human anatomy, providing surgeons with highly accurate models for preoperative planning. Stratasys collaborates with leading healthcare institutions and medical device companies, continuously pushing the boundaries of what is possible in medical innovation through additive manufacturing. The company’s solutions are pivotal in reducing time-to-market for new medical devices, enhancing surgical outcomes, and improving patient care.

Renishaw PLC is a UK-based engineering company specializing in precision measurement and healthcare technology, with a significant focus on 3D printing (additive manufacturing) for healthcare. The company is renowned for its advanced metal 3D printing systems, which are widely used in medical applications, including the production of customized implants and dental restorations. Renishaw’s expertise in additive manufacturing allows for the creation of complex, patient-specific medical devices that enhance surgical outcomes and reduce recovery times. The company also collaborates with healthcare providers and research institutions to develop cutting-edge solutions in areas such as cranial implants and orthopedic surgery. Renishaw's commitment to innovation is reflected in its continuous investment in research and development, positioning it as a leader in the integration of 3D printing technology within the healthcare sector.

3D Printing for Healthcare Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Free Sample Report

Recent Developments:

• In June 2022, Belgian contract manufacturer Amnovis and medical device service provider BAAT Medical entered into a partnership to offer an innovative and rapid turnaround process for 3D-printed medical devices.
• In February 2022, DeGen Medical Inc., a spinal implant manufacturer focused on augmented reality and patient-specific solutions, launched Impulse AM, a 3D-printed porous titanium implant for posterior interbody fusion.

Report Coverage:

By Technology

• Stereolithography (SLA)
• Selective Laser Sintering (SLS)
• Fused Deposition Modeling (FDM)
• Digital Light Processing (DLP)
• PolyJet Technology
• Others

By Product

• System
• Materials
• Services

By Application

• Medical Devices
• Prosthetics
• Implants
• Tissue Engineering
• Surgical Guides
• Others

By End-user

• Hospitals
• Clinics
• Academic Institutions
• Research Laboratories
• Biopharmaceutical Companies
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Aprecia Pharmaceuticals
• Aspect Biosystems
• Allegra
• Aurora Labs
• 3D Systems, Inc
• 3DMEDiTech
• Cyfuse Biomedical
• Digilab
• Envision TEC
• Luxexcel
• Materialise NV
• Nano3D Biosciences
• Oceanz BV
• Organovo Holdings, Inc
• Oventus Medical
• Stratasys Ltd
• Stryker Corporation
• Renishaw PLC
• Zimmer Biomet Holdings, Inc.
• Siemens Healthineers AG

Frequently Asked Questions (FAQs)